The role of splenectomy in the setting of refractory humoral rejection after kidney transplantation

Transplantation Proceedings

Volumn 44, Issue 5, 2012, Pages 1254-1258

  Tzvetanov, I ^a   Spaggiari, M ^a   Jeon, H ^a   Roca, R G ^a   Bhati, C ^a   Oberholzer, J ^a   Benedetti, E ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BORTEZOMIB; CREATININE; IMMUNOGLOBULIN G; RITUXIMAB;

ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE SEVERITY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LAPAROSCOPIC SURGERY; LIVING DONOR; MALE; PLASMAPHERESIS; PRESCRIPTION; PRIORITY JOURNAL; SEPSIS; SINGLE DRUG DOSE; SPLENECTOMY; TREATMENT RESPONSE; URINE VOLUME;

ADULT; CHICAGO; DESENSITIZATION, IMMUNOLOGIC; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS; IMMUNITY, HUMORAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PLASMAPHERESIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPLENECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84861870321     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.01.109     Document Type: Article

References (21)

1. Patel R, Terasaki PI: Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280:735, 1969
2. Williams GM, Hume DM, Hudson RP Jr, et al: "Hyperacute" renal-homograft rejection in man. N Engl J Med 279:611, 1968
3. Johnson AH, Rossen RD, Butler WT: Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: identification of low levels of pre-formed antibodies in accelerated allograft rejection. Tissue Antigens 2:215, 1972
4. Fuller TC, Phelan D, Gebel HM, et al: Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test. Transplantation 34:24, 1982
5. Cross DE, Whittier FC, Weaver P al: A comparison of the antiglobulin versus extended incubation time crossmatch: results in 223 renal transplants. Transplant Proc. 9:1803, 1977
6. Glotz D, Antoine C, Julia P, et al: Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2:758, 2002
7. Jordan SC, Quartel AW, Czer LS, et al: Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 66:800, 1998
8. Montgomery RA, Zachary AA, Racusen LC, et al: Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70:887, 2000
9. Warren DS, Zachary AA, Sonnenday CJ, et al: Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant 4:561, 2004
10. Zachary AA, Montgomery RA, Ratner LE, et al: Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 76:1519, 2003
11. Solez K, Colvin RB, Racusen LC, et al: Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ("CAN"). Am J Transplant 7:518, 2007
12. Magee CC: Transplantation across previously incompatible immunological barriers. Transpl Int 19:87, 2006
13. Kaplan B, Gangemi A, Thielke J, et al: Successful rescue of refractory, severe antibody mediated rejection with splenectomy. Transplantation 83:99, 2007
14. Locke JE, Zachary AA, Haas M, et al: The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection. Am J Transplant 7:842, 2007
15. Stegall MD, Dean PG, Gloor J: Mechanism of alloantibody production in sensitized renal allograft recipients. Am J Transplant 9:998, 2009
16. Sanz I, Wei C, Lee FE, et al: Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol 20:67, 2008
17. Kaposztas Z, Podder H, Mauiyyedi S, et al: Impact of rituximab therapy for treatment of acute humoral rejection. Clin Transplant 23:63, 2009
18. Lefaucheur C, Nochy D, Andrade J, et al: Comparison of combination plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection. Am J Transplant 9:1099, 2009
19. Stegall MD, Dean PG, Gloor J: Mechanisms of alloantibody production in sensitized renal allograft recipients. Am J Transplant 9:998, 2009
20. Cascio P, Oliva L, Cerruti F, et al: Dampening Ab responses using proteasome inhibitors following in vivo B cell activation. Eur J Immunol 38:658, 2008
21. Waiser J, Budde K, Schütz M, et al: Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection. Nephrol Dial Transplant 2011